Claritev Corp 8-K

What Happened
Claritev Corporation (CTEV) filed an 8-K (Regulation FD disclosure) on May 18, 2026 saying that in August 2024 it received a confidential grand jury subpoena from the Antitrust Division of the U.S. Department of Justice related to an investigation concerning health insurance. The company states it has been cooperating fully with the DOJ and that, "at no point in the subsequent two years has the DOJ informed the Company that it is the target of an investigation." The company is furnishing this information as required under Regulation FD.

Key Details

• Received a confidential grand jury subpoena from the DOJ Antitrust Division in August 2024.
• Matter relates to an investigation regarding health insurance.
• The company reports full cooperation with the DOJ since receipt of the subpoena.
• The company states the DOJ has not informed it that the company is a target at any point in the subsequent two years.
• Filing date: Form 8-K furnished May 18, 2026 (Regulation FD Disclosure, Item 7.01).

Why It Matters
This 8-K is a formal disclosure of a government investigation process that may be material to investors because it involves a DOJ subpoena and the Antitrust Division. The company emphasizes cooperation and notes it has not been told it is a target, which may reduce immediate legal risk compared with a target designation. Investors should monitor future filings and company updates for any developments, as additional disclosures would follow if the DOJ’s status or the investigation changes.